Galcanezumab for preventing migraine | TA659 | | |
Swallowable gastric balloon capsule for weight loss | IPG684 | | |
Acute coronary syndromes | NG185 | | |
Acute coronary syndromes in adults | QS68 | | |
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma | TA658 | | |
Magseed for locating impalpable breast cancer lesions | MIB236 | | |
NPi-200 for pupillary light reflex in critical care patients | MIB235 | | |
Human and animal bites: antimicrobial prescribing | NG184 | | |
Dexcom G6 for real-time continuous glucose monitoring | MIB233 | | |
Testing strategies for Lynch syndrome in people with endometrial cancer | DG42 | | |
Antimicrobial prescribing: imipenem with cilastatin and relebactam | ES30 | | |
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis | IPG681 | | |
Balloon cryoablation for Barrett's oesophagus | IPG682 | | |
Balloon cryoablation for squamous dysplasia of the oesophagus | IPG683 | | |
Tegaderm CHG securement dressing for vascular access sites | MIB231 | | |
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy | TA655 | | |
Volanesorsen for treating familial chylomicronaemia syndrome | HST13 | | |
Heavy menstrual bleeding | QS47 | | |
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer | TA653 | | |
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer | TA654 | | |
SEM Scanner 200 for preventing pressure ulcers | MTG51 | | |
Rheumatoid arthritis in adults: management | NG100 | | |
Behaviour change: digital and mobile health interventions | NG183 | | |
Pembrolizumab with axitinib for untreated advanced renal cell carcinoma | TA650 | | |
Naldemedine for treating opioid-induced constipation | TA651 | | |
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma | TA649 | | |
Transcranial magnetic stimulation for auditory hallucinations | IPG680 | | |
Novii Wireless Patch System for maternal and fetal monitoring | MIB228 | | |
Neuropathic pain in adults: pharmacological management in non-specialist settings | CG173 | | |
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes | MIB227 | | |
Insect bites and stings: antimicrobial prescribing | NG182 | | |
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) | TA648 | | |
Axonics sacral neuromodulation system for treating refractory overactive bladder | MTG50 | | |
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) | TA646 | | |
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal) | TA647 | | |
Avelumab with axitinib for untreated advanced renal cell carcinoma | TA645 | | |
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | DG41 | | |
Helge for detecting haemolysis | MIB225 | | |
Community pharmacies: promoting health and wellbeing | QS196 | | |
Faltering growth | QS197 | | |
High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | | |
FebriDx for C-reactive protein and myxovirus resistance protein A testing | MIB224 | | |
Anaphylaxis: assessment and referral after emergency treatment | CG134 | | |
Perioperative care in adults | NG180 | | |
Rehabilitation for adults with complex psychosis | NG181 | | |
Surgical site infections: prevention and treatment | NG125 | | |
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma | TA641 | | |
Gilteritinib for treating relapsed or refractory acute myeloid leukaemia | TA642 | | |
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer | TA643 | | |
Entrectinib for treating NTRK fusion-positive solid tumours | TA644 | | |